Xiamen Biotime Biotechnology Co., Ltd.
Who we are
Xiamen Biotime Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, production and sales of POCT in vitro diagnostic reagents. It has a scientific research team composed of dozens of masters and Ph.D. An executive team composed of senior talents with more than 20 years of industry experience as more than 250 employees. In just a few years, the company's performance has grown rapidly. It has successively obtained national high-tech enterprises, new research and development institutions in Fujian Province, leading companies in Fujian's science and technology giants, high-growth enterprises in the field of industrial and information technology in Fujian Province, and "specialized new" small and medium-sized enterprises in Fujian. More than 20 honorary qualifications including enterprises, Xiamen health brand enterprises, and innovative (pilot) enterprises in Xiamen City received capital assistance and completed a PreA round of financing of 30 million yuan.
The company is positioned for the research of POCT precision medical rapid diagnosis related technologies. The technology platform covers quantitative detection of fluorescence immunochromatography, high performance liquid chromatography, mass spectrometry, electrochemical coagulation, photoexcited chemiluminescence, molecular POCT and other precise diagnostic technologies, and has obtained more than 30 items of core independent intellectual property authorization. Biotime aims to develop internationally leading medical diagnostic reagents to promote the development of modern laboratory technology and to improve disease prevention and treatment
As of 2019, more than 50 test items such as maternal and infant health series, hormone series, myocardial series, and tumor series have been developed. In vitro diagnostic reagents and instruments have all obtained medical device registration certificates. Biotime havs obtained CE certification for more than 35 products. At the same time, the company is committed to the integration of upstream and downstream industrial chains, independently building a raw material development platform, controlling the core raw material sources for the development of diagnostic reagents, ensuring the stability of materials, improving product quality, and continuously enhancing the market competitiveness of enterprises.
Sincerity, Efficiency, Innovation, Team Work, Win-Win, Transcendence